Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,688 | 19,661 | 14,544 | 16,225 | 15,927 |
| Receivables | 93,462 | 90,743 | 89,525 | 89,204 | 104,645 |
| Inventories | 32,517 | 32,586 | 33,382 | 31,314 | 33,865 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 550 |
| Other current assets | 88 | 1,081 | 11,749 | 19,865 | 0 |
| TOTAL | $152,119 | $155,282 | $159,335 | $166,953 | $164,726 |
| Non-Current Assets | |||||
| PPE Net | 81,236 | 81,892 | 84,079 | 87,336 | 95,339 |
| Intangibles | 138,217 | 138,218 | 138,244 | 138,276 | 149,776 |
| Other Non-Current Assets | 8,807 | 8,919 | 21,402 | 34,166 | 9,425 |
| TOTAL | $228,260 | $229,029 | $243,725 | $259,778 | $254,540 |
| Total Assets | $380,379 | $384,311 | $403,060 | $426,731 | $419,266 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 400 | 1,058 | 2,108 | 3,417 | 687 |
| Accounts payable and accrued liabilities | 25,585 | 24,123 | 21,885 | 25,490 | 24,671 |
| Accrued Expenses | 16,321 | 17,060 | 13,734 | 14,081 | 12,542 |
| TOTAL | $59,059 | $59,091 | $55,607 | $61,874 | $53,817 |
| Non-Current Liabilities | |||||
| Long Term Debt | 117,331 | 119,370 | 125,562 | 124,684 | 125,640 |
| Deferred Revenues | N/A | N/A | N/A | 2,085 | N/A |
| Other Non-Current Liabilities | 16,539 | 17,611 | 15,222 | 19,761 | 11,626 |
| TOTAL | $134,756 | $137,756 | $141,567 | $144,445 | $141,113 |
| Total Liabilities | $193,815 | $196,847 | $197,174 | $206,319 | $194,930 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,575 | 53,215 | 54,488 | 55,256 | 56,348 |
| Common Shares | 482 | 515 | 513 | 509 | 547 |
| Retained earnings | 101,187 | 93,882 | 91,410 | 97,947 | 90,934 |
| Other shareholders' equity | -2,666 | 406 | -410 | 409 | 212 |
| TOTAL | $186,564 | $187,464 | $205,886 | $220,412 | $224,336 |
| Total Liabilities And Equity | $380,379 | $384,311 | $403,060 | $426,731 | $419,266 |